100% In House
PHARMACEUTICALS
(time to market)
Under development:
- 3 Injectable/lyophilised (>2 years)
- 2 β-lactam antibiotic (>2 years)
Planned submission:
- 1 β-lactam antibiotic (2 years)
Under submission:
- 3 Injectable/lyophilised (1 year)
- 2 β-lactam antibiotic (1 year)
Out of Patent
Collaboration (RJF + University + Start-up)
PHARMACEUTICALS / MEDICAL DEVICE / FOOD SUPPLEMENT (time to market)
Under development:
- Biosimilar (>2 years)
Clinical data presentation:
- Fungic infection – Phase III (>2 years)
- Nife-Par – Post Approval
- GynEC – Post Approval
Under submission:
- Impetigo (1 year)
Pre-market:
- Nail regeneration
- Men fertility
- Molluscum